Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.42 |
| ▸ | DRD2 | P14416 | 7/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.40 |
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL27955397 | 0.93 | SIGMAR1 (0.42) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL6341038 | 0.92 | CFTR (0.44) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL37303 | 0.92 | CFTR (0.44) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL29390919 | 0.92 | CFTR (0.44) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| Acetone SCHEMBL3494828 | 0.91 | SIGMAR1 (0.40) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| Ammonia Solution, Strong SCHEMBL13731210 | 0.90 | CFTR (0.42) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| Isothiocyanate SCHEMBL16059997 | 0.84 | CFTR (0.38) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| Allylamine SCHEMBL11236327 | 0.84 | SIGMAR1 (0.42) | SIGMAR1DRD2SMN1; SMN2GRIN2DGRIN3B | |
| SCHEMBL11314758 | 0.82 | PTPRC (0.39) | SIGMAR1DRD2SMN1; SMN2CFTRGOPC | |
| SCHEMBL11312792 | 0.81 | ALDH1A1 (0.39) | SIGMAR1DRD2SMN1; SMN2CFTRGOPC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6852334-B1 | Cationic peg-lipids and methods of use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2005-02-08 | — | — | US | disclosed |
| US-20040241855-A1 | Cationic peg-lipids and methods of use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2004-12-02 | — | — | US | disclosed |
| EP-1173600-A2 | CATIONIC PEG-LIPIDS AND METHODS OF USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-01-23 | — | — | EP | disclosed |
| WO-2000062813-A2 | CATIONIC PEG-LIPIDS AND METHODS OF USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2000-10-26 | — | — | WO | disclosed |